Interés Humano

Agencia europea afirma que casos de la variante ómicron son ‘leves’ en su mayoría

La OMS señaló que podría provocar una mayor tasa de reinfección, pero provoca síntomas menos graves

A patient gets vaccinated against COVID-19 at the Witkoppen clinic in Johannesburg on December 8, 2021. - Anti-Covid vaccines may lose effectiveness against Omicron, but one more dose could remedy this. Initial elements, notably given by the Pfizer laboratory, shed light on the capacity of the new variant to resist vaccination. Omicron is "probably not sufficiently neutralized after two doses", admitted Wednesday the groups Pfizer and BioNTech, whose anti-Covid vaccine is given in two injections. (Photo by EMMANUEL CROSET / AFP)
A patient gets vaccinated against COVID-19 at the Witkoppen clinic in Johannesburg on December 8, 2021. - Anti-Covid vaccines may lose effectiveness against Omicron, but one more dose could remedy this. Initial elements, notably given by the Pfizer laboratory, shed light on the capacity of the new variant to resist vaccination. Omicron is "probably not sufficiently neutralized after two doses", admitted Wednesday the groups Pfizer and BioNTech, whose anti-Covid vaccine is given in two injections. (Photo by EMMANUEL CROSET / AFP) EMMANUEL CROSET
‌
‌

‌

‌
‌

‌

‌